News

The annual list of the world's Highly Cited Researches was released on November 15, 2022. The Editorial Office of Journal of Cancer Metastasis and Treatment is proud to announce that Associate Editor Prof. Jesús F. San-Miguel and Editorial Board member Prof. Giuseppe Curigliano have been named to the Highly Cited Researchers 2022 list by Clarivate. Sincere congratulations to the researchers!

On August 24, 2022, the Editorial Office of Journal of Cancer Metastasis and Treatment (JCMT) was very honored to interview Prof. Steven N. Fiering who is from Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, United States.

On August 16, 2022, the Editorial Office of Journal of Cancer Metastasis and Treatment (JCMT) was very honored to interview journal Associate Editor Prof. Ciro Isidoro who is full Professor of General Pathology and Immunology and of Experimental Oncology at the Università del Piemonte Orientale "A. Avogadro", Novara, Italy.

On August 1, 2022, the Editorial Office of Journal of Cancer Metastasis and Treatment (JCMT) was very honored to interview journal Associate Editor Dr. Andrea Nicolini, an outstanding expert in breast and gastrointestinal cancer and their metastases, from Department of Internal Medicine, University of Pisa, Santa Chiara Hospital, Pisa, Italy.

On July 13, the Editorial Office of Journal of Cancer Metastasis and Treatment interviewed the Editor-in-Chief Lucio Miele, who talked about his current research, advice to young scholars and his plans for the future development of the journal. From this video interview, let us take a look at what Prof. Miele has said.

The First Editorial Board meeting of the Journal of Cancer Metastasis and Treatment (JCMT) was successfully held on February 21, 2022. Ten Editorial Board members participated in the meeting.

We are pleased to announce that Journal of Cancer Metastasis and Treatment (JCMT, Online ISSN: 2454-2857 Print ISSN: 2394-4722, Publisher: OAE Publishing Inc.)

In 2021, JCMT journal made considerable progress and breakthroughs. On the occasion of the coming of the new year, the Editorial Office would like to express our sincere gratitude to all the authors, readers, reviewers, and Editorial Board members who have always supported JCMT.

On November 16, 2021, Clarivate Analytics announced the list of “Highly Cited Researchers 2021”. Three Editorial Board Members of Journal of Cancer Metastasis and Treatment (JCMT) are on the list.

The international webinar "Metastatic Renal Cell Carcinoma", chaired by Professor Hendrik Paul Van Poppel, the Chairman of the Department of Urology at the University Hospital Gasthuisberg, Katholieke Universiteit (KU) Leuven, Belgium, was successfully held on August 16th, 2021.

Jerome M. Hershman, M.D., M.S., is Distinguished Professor of Medicine Emeritus at the David Geffen School of Medicine at University of California, Los Angeles (UCLA) and Director of the Endocrine Clinic at the West Los Angeles VA Medical Center.

The First Editorial Board Meeting of Journal of Cancer Metastasis and Treatment (JCMT) in 2021 was successfully held on June 21, 2021. 47 Editorial Board members from 12 countries participated in the meeting.

The continuous progress of Journal of Cancer Metastasis and Treatment (JCMT) in 2020 depends on the contributions of anonymous but dedicated researchers providing constructive suggestions on our manuscripts.

This has been a challenging year for everyone. However, despite the challenges of the pandemic, our journal has made significant progress. In 2020, we were fortunate to receive the support from the Editorial Board Members, Guest Editors, authors, reviewers, readers and all the contributors.

To provide young scholars with an active academic exchange platform for exchanging ideas with each other and with influential experts in cancer metastasis and treatment, and cultivate candidates for Editorial Board of Journal of Cancer Metastasis and Treatment (JCMT), the Editorial Office plans to recruit junior Editorial Board members worldwide from now on.

We are very pleased to announce the successful completion of reorganizing the Editorial Board of Journal of Cancer Metastasis and Treatment (JCMT) from March to August 2020. During this course, a total of 37 internationally-recognized researchers have formally joined the Editorial Board of JCMT with the ambition to support our future development.

Thank you all for your attention and help to Journal of Cancer Metastasis and Treatment in the past year.

Editorial office of Journal of Cancer Metastasis and Treatment (JCMT) is delighted to announce that JCMT has adopted MESAs, a brand-new online submission & review system from March 21, 2019, to provide superior publishing experience for our users.

We are pleased to announce that Journal of Cancer Metastasis and Treatment (JCMT) is now a member of the Committee on Publication Ethics (COPE).

We know that many editors, authors, reviewers, and readers are very concerned about the impact of Journal of Cancer Metastasis and Treatment (JCMT). Then we hereby report the citations of the journal articles. In total, JCMT published 67 and 41 articles in 2016 and 2017, respectively. Among them, 63 and 35 were Review, Original article or Case report in 2016 and 2017, respectively. 31 of these articles were cited 67 times in 2018 by articles indexed in Web of Science (as of January 21, 2019). All the cited articles are listed below.

On January 15, 2019, Annual Report meeting of Journal of Cancer Metastasis and Treatment (JCMT) was held in Beijing, China. The report on the development of the journal over the past year was given by JCMT Editorial Office, which reads as follows.

The continued success of Journal of Cancer Metastasis and Treatment (JCMT) in 2018 depends on the contributions of anonymous but dedicated researchers who providing constructive feedbacks on our manuscripts. These dedicated people give freely of their time and expertise to the journal. 

On January 25 2018, the 2017 Annual Report Meeting of Journal of Cancer Metastasis and Treatment (JCMT) was held. All members from the editorial office attended this conference, and Carrie Wang, the Managing Editor of the journal made the Annual Report of JCMT to all the attendees.

The 108th American Association for Cancer Research (AACR) Annual Meeting was held in Washingtonfrom April 1 to 5, 2017. Cancer experts and scholars from around the world participated in this grand event. Dandan Yu, Manager Editor of OAE publishing Inc., and Lisa Huang, the Assistant Editor of Journal of Cancer Metastasis and Treatment (JCMT), attended the meeting with the aimsof exchanging opinions with peers and promoting JCMT.

Prostate cancer (PCa) is the fourth most frequent cancer and the second most common cancer in men. Approximately 1.1 million cases of PCa were diagnosed worldwide in 2012, accounting for 15% of all cancers in men [Ferlay et al., Int J Cancer 2015;136:E359e86.]. Although advances in both PCa biology and precision medicine have improved the clinical outcome, the overall impact on survival rates has been relatively modest, leaving metastasised or recurrent disease largely incurable by conventional approaches and requiring the development of better therapeutics.

On January 10, 2017, 2016 Annual Report of Journal of Cancer Metastasis and Treatment was held. As Managing Editor, Lisa Huang presented an overall review of the development of the journal over the past year to all members of the editorial office. A summary of the key events of what has been a very busy year follows.

Univ.-Prof. Dr. Ira-Ida Skvortsova, Laboratory for Experimental and Translational Radiation Oncology (EXTRO-Lab), Dept. of Therapeutic Radiology and Oncology, Medical University of Innsbruck, Anichstr. 35, A-6020 Innsbruck, AUSTRIA; Tel: ++43-512-504-27758 (Lab:-27757); Fax: ++43-512-504-27756; E-Mail: Ira.Skvortsova@i-med.ac.at; Ira.Skvortsova@tirol-kliniken.at

September 12, 2016, this meeting was held. Prof. Dai-Ming Fan discussed every part and provided insightful suggestions as well as gave a great vision that Journal of Cancer Metastasis and Treatment (JCMT)

Academician Yan Sun joins Journal of Cancer Metastasis and Treatment (JCMT) as Honorary Editor-in-Chief on September 23, 2016. This gives us a great impetus again after Academician Dai-Ming Fan joined us.

The 19th National Clinical Oncology Congress & Chinese Society of Clinical Oncology (CSCO) was held from September 21–25, 2016, in Xiamen, China. The editorial team (Ling Huang and A-ni Yuan) of the Journal of Cancer Metastasis and Treatment (JCMT) and Dan-dan Yu, the publication manager of OAE Publishing Inc., took part in the conference.

In co-incidence with the AACR Annual Meeting 2016, Journal of Cancer Metastasis and Treatment (JCMT) held its very first Editorial Board meeting on April 16, 2016 at the RUTH’S CHRIS restaurant located at 525 Fulton St, New Orleans, Louisiaa, USA.  The attendees included JCMT Editor-in-Chief

Prof. Yaguang Xi, of Mitchell Cancer Institute, University of South Alabama (Alabama, USA) was invited to visit our Editorial Office of Journal of Cancer Metastasis and Treatment (JCMT) during a short-term academic exchange on August 10, 2015.

Since June, 2015, the Journal of Cancer Metastasis and Treatment (JCMT) has established a preliminary cooperation with European Organization for Research and Treatment of Cancer (EORTC) in terms of mutual contact and advertisement.